Updated estimates of neural tube defects prevented by mandatory folic Acid fortification - United States, 1995-2011
Jennifer Williams, Cara T Mai, Joe Mulinare, Jennifer Isenburg, Timothy J Flood, Mary Ethen, Barbara Frohnert, Russell S Kirby, Centers for Disease Control and Prevention, Jennifer Williams, Cara T Mai, Joe Mulinare, Jennifer Isenburg, Timothy J Flood, Mary Ethen, Barbara Frohnert, Russell S Kirby, Centers for Disease Control and Prevention
Abstract
In 1992, the U.S. Public Health Service recommended that all women capable of becoming pregnant consume 400 µg of folic acid daily to prevent neural tube defects (NTDs). NTDs are major birth defects of the brain and spine that occur early in pregnancy as a result of improper closure of the embryonic neural tube, which can lead to death or varying degrees of disability. The two most common NTDs are anencephaly and spina bifida. Beginning in 1998, the United States mandated fortification of enriched cereal grain products with 140 µg of folic acid per 100 g. Immediately after mandatory fortification, the birth prevalence of NTD cases declined. Fortification was estimated to avert approximately 1,000 NTD-affected pregnancies annually. To provide updated estimates of the birth prevalence of NTDs in the period after introduction of mandatory folic acid fortification (i.e., the post-fortification period), data from 19 population-based birth defects surveillance programs in the United States, covering the years 1999-2011, were examined. After the initial decrease, NTD birth prevalence during the post-fortification period has remained relatively stable. The number of births occurring annually without NTDs that would otherwise have been affected is approximately 1,326 (95% confidence interval = 1,122-1,531). Mandatory folic acid fortification remains an effective public health intervention. There remain opportunities for prevention among women with lower folic acid intakes, especially among Hispanic women, to further reduce the prevalence of NTDs in the United States.
Figures
References
- CDC. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep. 1992;41(RR-14)
- CDC. CDC Grand Rounds: additional opportunities to prevent neural tube defects with folic acid fortification. MMWR Morbid Mortal Wkly Rep. 2010;59:980–4.
- CDC. Spina bifida and anencephaly before and after folic acid mandate—United States, 1995–1996 and 1999–2000. MMWR Morbid Mortal Wkly Rep. 2004;53:362–5.
- Grosse SD, Ouyang L, Collins JS, Green D, Dean JH, Stevenson RE. Economic evaluation of a neural tube defect recurrence-prevention program. Am J Prev Med. 2008;35:572–7.
- Pfeiffer CM, Hughes JP, Lacher DA, et al. Estimation of trends in serum and RBC folate in the United States population from pre- to post-fortification using assay-adjusted data from the NHANES 1988–2010. J Nutr. 2012;142:886–93.
- Crider KS, Devine O, Hao L, et al. Population red blood cell folate concentrations for prevention of neural tube defects: Bayesian model. BMJ. 2014;349:g4554.
- Tinker SC, Hamner H, Crider KS. Red blood cell folate concentrations among non-pregnant United States women of childbearing age, National Health and Nutrition Examination Survey, 2007–2010. Available at .
- Tinker SC, Cogswell ME, Devine O, Berry RJ. Folic acid intake among United States women aged 15–44 years, National Health and Nutrition Examination Survey, 2003–2006. Am J Prev Med. 2010;38:534–42.
- Crider KS, Zhu JH, Ling H, et al. MTHFR 677C→T genotype is associated with folate and homocysteine concentrations in a large population-based, double blind trial of folic acid supplementation. Am J Clin Nutr. 2011;93:1365–72.
- Tinker SC, Devine O, Mai C, et al. Estimate of the potential impact of folic acid fortification of corn masa flour on the prevention of neural tube defects. Birth Defects Res A Clin Mol Teratol. 2013;97:649–57.
Source: PubMed